Filing Flows › Cytokinetics (CYTK) › Collaboration Revenues revenue
Cytokinetics (CYTK) Collaboration Revenues revenue by quarter
Cytokinetics' Collaboration Revenues revenue was $3.0M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 5 quarters it ranged from $2.4M (Q2 2025) to $3.3M (Q2 2026).
| Quarter | Collaboration Revenues revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.0M | -7% | — |
| Q2 2026 | $3.3M | +25% | +36% |
| Q1 2026 | $2.6M | -4% | — |
| Q4 2025 | $2.8M | +14% | — |
| Q2 2025 | $2.4M | — | — |
Q3 2026 at a glance
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cytokinetics' Collaboration Revenues revenue?
Cytokinetics' Collaboration Revenues revenue was $3.0M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has Cytokinetics' Collaboration Revenues revenue changed?
Over the last 5 quarters it ranged from $2.4M (Q2 2025) to $3.3M (Q2 2026).